IBDEI0TK ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13301,1,4,0)
 ;;=4^H35.3122
 ;;^UTILITY(U,$J,358.3,13301,2)
 ;;=^5138507
 ;;^UTILITY(U,$J,358.3,13302,0)
 ;;=H35.3123^^51^633^10
 ;;^UTILITY(U,$J,358.3,13302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13302,1,3,0)
 ;;=3^NonEx AMD,OS,Adv Atrpc w/o Sbfvl Invlv
 ;;^UTILITY(U,$J,358.3,13302,1,4,0)
 ;;=4^H35.3123
 ;;^UTILITY(U,$J,358.3,13302,2)
 ;;=^5138508
 ;;^UTILITY(U,$J,358.3,13303,0)
 ;;=H35.3124^^51^633^11
 ;;^UTILITY(U,$J,358.3,13303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13303,1,3,0)
 ;;=3^NonEx AMD,OS,Adv Atrpc w/ Sbfvl Invlv
 ;;^UTILITY(U,$J,358.3,13303,1,4,0)
 ;;=4^H35.3124
 ;;^UTILITY(U,$J,358.3,13303,2)
 ;;=^5138509
 ;;^UTILITY(U,$J,358.3,13304,0)
 ;;=H35.3110^^51^633^2
 ;;^UTILITY(U,$J,358.3,13304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13304,1,3,0)
 ;;=3^NonEx AMD,OD,Stage Unspec
 ;;^UTILITY(U,$J,358.3,13304,1,4,0)
 ;;=4^H35.3110
 ;;^UTILITY(U,$J,358.3,13304,2)
 ;;=^5138500
 ;;^UTILITY(U,$J,358.3,13305,0)
 ;;=H35.3111^^51^633^3
 ;;^UTILITY(U,$J,358.3,13305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13305,1,3,0)
 ;;=3^NonEx AMD,OD,Early Dry Stage
 ;;^UTILITY(U,$J,358.3,13305,1,4,0)
 ;;=4^H35.3111
 ;;^UTILITY(U,$J,358.3,13305,2)
 ;;=^5138501
 ;;^UTILITY(U,$J,358.3,13306,0)
 ;;=H35.3112^^51^633^4
 ;;^UTILITY(U,$J,358.3,13306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13306,1,3,0)
 ;;=3^NonEx AMD,OD,Intermed Dry Stage
 ;;^UTILITY(U,$J,358.3,13306,1,4,0)
 ;;=4^H35.3112
 ;;^UTILITY(U,$J,358.3,13306,2)
 ;;=^5138502
 ;;^UTILITY(U,$J,358.3,13307,0)
 ;;=H35.3113^^51^633^5
 ;;^UTILITY(U,$J,358.3,13307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13307,1,3,0)
 ;;=3^NonEx AMD,OD,Adv Atrpc w/o Sbfvl Invlv
 ;;^UTILITY(U,$J,358.3,13307,1,4,0)
 ;;=4^H35.3113
 ;;^UTILITY(U,$J,358.3,13307,2)
 ;;=^5138503
 ;;^UTILITY(U,$J,358.3,13308,0)
 ;;=H35.3114^^51^633^6
 ;;^UTILITY(U,$J,358.3,13308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13308,1,3,0)
 ;;=3^NonEx AMD,OD,Adv Atrpc w/ Subfvl Invlv
 ;;^UTILITY(U,$J,358.3,13308,1,4,0)
 ;;=4^H35.3114
 ;;^UTILITY(U,$J,358.3,13308,2)
 ;;=^5138504
 ;;^UTILITY(U,$J,358.3,13309,0)
 ;;=H32.^^51^634^12
 ;;^UTILITY(U,$J,358.3,13309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13309,1,3,0)
 ;;=3^Chorioretinal Disorders,Secondary,Unspec
 ;;^UTILITY(U,$J,358.3,13309,1,4,0)
 ;;=4^H32.
 ;;^UTILITY(U,$J,358.3,13309,2)
 ;;=^5005489
 ;;^UTILITY(U,$J,358.3,13310,0)
 ;;=H30.93^^51^634^11
 ;;^UTILITY(U,$J,358.3,13310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13310,1,3,0)
 ;;=3^Chorioretinal Inflammation,Unspec,OU
 ;;^UTILITY(U,$J,358.3,13310,1,4,0)
 ;;=4^H30.93
 ;;^UTILITY(U,$J,358.3,13310,2)
 ;;=^5005435
 ;;^UTILITY(U,$J,358.3,13311,0)
 ;;=H30.91^^51^634^9
 ;;^UTILITY(U,$J,358.3,13311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13311,1,3,0)
 ;;=3^Chorioretinal Inflammation,Unspec,OD
 ;;^UTILITY(U,$J,358.3,13311,1,4,0)
 ;;=4^H30.91
 ;;^UTILITY(U,$J,358.3,13311,2)
 ;;=^5133481
 ;;^UTILITY(U,$J,358.3,13312,0)
 ;;=H30.92^^51^634^10
 ;;^UTILITY(U,$J,358.3,13312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13312,1,3,0)
 ;;=3^Chorioretinal Inflammation,Unspec,OS
 ;;^UTILITY(U,$J,358.3,13312,1,4,0)
 ;;=4^H30.92
 ;;^UTILITY(U,$J,358.3,13312,2)
 ;;=^5133482
 ;;^UTILITY(U,$J,358.3,13313,0)
 ;;=H31.003^^51^634^15
 ;;^UTILITY(U,$J,358.3,13313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13313,1,3,0)
 ;;=3^Chorioretinal Scars,Unspec,OU
 ;;^UTILITY(U,$J,358.3,13313,1,4,0)
 ;;=4^H31.003
